Click to Share
 
 
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
News By Tag
Erythropoietin Receptor Remove


April 2015
Sa Fr Th We Tu Mo Su
25 24 23 22 21 20 19

erythropoietin receptor Press Releases

  + XML/RSS  



By STATegics, Inc.
STATegics, Inc. announced today that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the company a second grant to advance its proprietary agonists of the tissue-protective erythropoietin receptor for the treatment of...
By STATegics, Inc.
STATegics, Inc. announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded the company a grant to advance its proprietary erythropoietin receptor agonist compounds for the treatment of acute kidney...
By STATegics, Inc.
The Michael J. Fox Foundation Awards Grant to Support STATegics’ Preclinical Studies of Small Molecule Erythropoietin Receptor Agonists for the Treatment of Parkinson’s Disease
By STATegics, Inc.
STATegics, Inc. awarded a new grant from the Friedreich’s Ataxia Research Alliance (FARA) to advance erythropoietin receptor agonist compounds for the treatment of Friedreich’s ataxia (FRDA).

All Press Releases

By STATegics, Inc.
STATegics, Inc. announced today that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the company a second grant to advance its proprietary agonists of the tissue-protective erythropoietin receptor for the treatment of...
By STATegics, Inc.
STATegics, Inc. announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded the company a grant to advance its proprietary erythropoietin receptor agonist compounds for the treatment of acute kidney...
By STATegics, Inc.
The Michael J. Fox Foundation Awards Grant to Support STATegics’ Preclinical Studies of Small Molecule Erythropoietin Receptor Agonists for the Treatment of Parkinson’s Disease
By STATegics, Inc.
STATegics, Inc. awarded a new grant from the Friedreich’s Ataxia Research Alliance (FARA) to advance erythropoietin receptor agonist compounds for the treatment of Friedreich’s ataxia (FRDA).


Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share